InsidersTradesSigma
Discover the complete record of transactions filed by Jörgen Dahlström, Director. Officer active across 2 companies, notably Prostatype Genomics AB. Aggregated, 1 reports have been logged. The latest transaction was disclosed on 9 June 2025 — Purchase. Regulator: FIN-FSA. All data is openly available.
1 of 1 declaration
Jörgen Dahlström is a Board Member of Prostatype Genomics AB, where he participates in the governance and strategy of the company. His expertise in the biotechnology sector is valuable for the development of Prostatype.